Asahi Kasei Corporation products

Designed for 1 unit of whole blood (WB) for laboratory use; High leukocyte reduction (Residual leukocytes averaging below 1x 106); High post-filtration whole blood volume recovery greater than 90% on average; Rapid priming directly with whole blood and consistent flow rate.

Designed for 1 unit of Red Blood Cell (RBC) for INLINE; High leukocyte reduction (Residual leukocytes averaging below 1x 106); High consistency and reliability of performance; Ease of use and priming; Minimum filter-housing dead volume; High efficiency PLT removal.

Reclast® is a bisphosphonate agent that suppresses bone resorption, for the treatment of osteoporosis. Reclast® is capable of a year-long treatment with once-a-year intravenous infusion. Reclast® is a registered trademark of Novartis.

Teribone™ is a human parathyroid hormone preparation that facilitates bone formation, for the indication of osteoporosis with high risk of fracture. With weekly or twice weekly subcutaneous injections, Teribone™ decreases the risk of developing new vertebral fracture.

Elcitonin™ Injection 20S has superior efficacy in alleviating pain associated with osteoporosis while suppressing its concomitant bone loss.